Please enable JavaScript to view the site.

Viewing offline content

Limited functionality available

Dismiss

Services
What's New
Industries
What's New
Insights
What's New
Careers
What's New
- Students
  Your success is our focus. From internships to on-the-job training, there’s plenty of room for your career to grow for years to come. Apply today and join us. We can impact the world—together.
- Deloitte's Talent Network
  Inspiring connections. Impactful work. All here. All waiting to be discovered by you. When you join our Talent Network, you're connecting to career resources that provide insights into working at Deloitte and potential job opportunities. Let's get started.
US-EN Location: United States-English
Contact us

US-EN Location: United States-English
Contact us

Life Sciences

Across life sciences, you’ll find innovators who are developing therapies, treatments, devices, and cures for society’s most pressing health challenges. Alongside them, you will find Deloitte. We connect the right people, partners, and technologies to orchestrate and deliver the business of science.

Subscribe

All
Solutions
People

Explore our content

Select a filter.

Insert Custom HTML fragment. Do not delete! This box/component contains code that is needed on this page. This message will not be visible when page is activated.
+++ DO NOT USE THIS FRAGMENT WITHOUT EXPLICIT APPROVAL FROM THE CREATIVE STUDIO DEVELOPMENT TEAM +++

Deloitte Platforms Navigation. Do not delete! This box/component contains JavaScript that is needed on this page. This message will not be visible when page is activated.

Featured Highlights

Blog

2024 outlook for life sciences

Digital transformation, generative artificial intelligence (AI), and the adoption of virtual health/digital tools are the three trends most likely to impact medical device manufacturers in 2024, according to a survey of C-suite executives conducted by the Deloitte Center for Health Solutions.

Digital transformation, generative artificial intelligence (AI), and the adoption of virtual health/digital tools are the three trends most likely to impact medical device manufacturers in 2024, according to a survey of C-suite executives conducted by the Deloitte Center for Health Solutions.

Blog

Can life sciences companies unlock the full value of GenAI?

GenAI is an inevitability in Life Science: Four areas where we expect to see leapfrog domain plays.

Analysis

Measuring the return from pharmaceutical innovation 2024

Our latest report looks at the current state of R&D returns for 20 leading biopharma companies; how to streamline clinical trials, optimize pipeline value, and leverage AI and analytics to boost productivity and ROI.

Perspectives

Digitalized supply chains are essential to biopharma's future

Research reveals where the biopharma industry is on its supply chain digitalization journey.

Perspectives

Drug launches reflect overall company performance

Uncovering the lessons large pharma companies could learn from their smaller rivals’ drug launch strategies.

Perspectives

Has medtech entered the era of digital innovation?

How medtech companies are employing digital technologies to grow, innovate, and develop a competitive edge.

Perspectives

Tech Trends 2023: A life sciences perspective

Discover how your business can embrace six emerging life sciences technology trends to gain a competitive edge.

Tales of Transformation: A Life Sciences and Health Care Podcast Series

Hear how life sciences and health care leaders are adapting to change within the industry.

AI & Digital Transformation

Analysis

Algorithm to lab, explore Generative AI’s impact in life sciences

Insights to drive value and a competitive advantage

For life sciences companies, embarking on the generative AI journey doesn’t have to be perilous. Chart your course with insights from our blogs.

Perspectives

Digital transformation in life sciences

How pharma and medtech can shift from doing digital to being digital

Digital transformation is no longer a buzzword—it’s a strategic imperative. How can life sciences companies advance their capabilities and take a more holistic view of their digital strategies?

Perspectives

Tech Trends 2023: A life sciences perspective

Discover how your business can embrace six emerging life sciences technology trends to gain a competitive edge.

Let’s make this work.

To view this video, change your analytics/performance cookie settings.

Analysis

Biopharma digital maturity benchmark assessment

How does your company’s tech innovation stack up against the competition?

Perspectives

Has medtech entered the era of digital innovation?

How medtech companies are employing digital technologies to grow, innovate, and develop a competitive edge.

Podcast

Code Green

A life sciences and health care cybersecurity podcast series

R&D, Clinical Innovation

Perspectives

Life sciences research and development insights

Reshaping R&D innovation. Data-driven. Digitally enabled. Patient-focused.

Analysis

Measuring the return from pharmaceutical innovation 2024

Our latest report looks at the current state of R&D returns for 20 leading biopharma companies; how to streamline clinical trials, optimize pipeline value, and leverage AI and analytics to boost productivity and ROI.

Perspectives

Broadening research participation through community engagement

How community health centers can partner with traditional research institutions and tap into their community resources to help make clinical trials more inclusive and equitable.

About us

CognitiveSpark™ for Regulatory

Amplify insights for your regulatory submissions and strategies with CognitiveSpark™ for Regulatory.

Deloitte Insights

Enhancing clinical trial diversity

Stakeholder perspectives on advancing research through representative clinical trials

Blog

Retail Clinics May be the Next Frontier for Clinical Trials

Could clinical trials move to grocery store and pharmacy chains?

Blog

Generative AI could help accelerate clinical development

Three processes that could be improved with generative AI.

Let’s make this work.

To view this video, change your analytics/performance cookie settings.

Supply Chain

Perspectives

Life sciences supply chain

Driving better performance and patient outcomes

The life sciences industry is facing challenges such as growth and profitability focus that has resulted in a global manufacturing footprint while mega mergers are driving the need for significant synergies.

Perspectives

Digitalized supply chains are essential to biopharma's future

Research reveals where the biopharma industry is on its supply chain digitalization journey.

Perspectives

Making biopharma’s supply chains more environmentally sustainable

Survey findings show pharma's progress on reducing the supply chain's environmental footprint.

Blog

Did removing weak links make pharma supply chains stronger?

Why evaluating supply chain risk should be a priority for biopharma companies.

Let’s make this work.

To view this video, change your analytics/performance cookie settings.

Commercial

Perspectives

Reimagining commercial models in life sciences

For many life science companies, the commercial models utilized to market pharmaceutical products no longer support business objectives.

Strengthen your company’s sales, marketing, patient services, and commercial model strategies through data and advanced analytics.

Perspectives

State drug price transparency

Operational considerations for drug pricing regulation

Operational considerations for manufacturers to understand how to remain compliant as new state drug pricing transparency legislations are enacted.

Blog

Medical Affairs: Evolving to be true strategic partners

3 Key trends that could help transform Medical Affairs into a strategic partner.

Perspectives

Drug launches reflect overall company performance

Let’s make this work.

To view this video, change your targeting/advertising cookie settings.

CognitiveSpark™ for Marketing: An Artificial Intelligence (AI) Solution | ConvergeHEALTH

Medtech

Medical Technology

The next generation of medical technology has the potential to shape the entire health care industry. Find out where Medical Technology (MedTech) transformation could take you.

Article

Can the current big thing get in the next big thing’s way?

How consolidating systems at a financial institution meant more time for clients.A MedTech company explores a strategy for building emerging skillsets and optimizing traditional ones to accelerate product development and commercialization.

Blog

Digital medtech, FemTech, GeriTech among topics at J.P. Morgan

FemTech and GeriTech appear to be gaining traction in medtech.

Blog

In a digital goldrush, how can medtech stake its claim?

Perspectives

Has medtech entered the era of digital innovation?

Advanced Therapies

Analysis

NextGen cell and gene therapy

Personalized precision medicine is here

Advancements in next-generation cell and gene therapies are fulfilling the promise of personalized medicine and attempting to cure and heal patients rather than ameliorating symptoms. Multiple approved products have been launched in global markets and the number of clinical trials continues to grow.

Perspectives

CGT Market Index

Insights for CFOs

Podcast

Cell and gene therapy insights

Curing complexity in the future of personalized medicine

Guest leaders from Novartis and the Mayo Clinic join the podcast to discuss the challenges and opportunities arising from cell and gene manufacturing.

Blog

The evolution and future of cell & gene therapy

Why cell & gene therapy manufacturers should work more closely with health systems.

Perspectives

2023 cell and gene therapy industry survey

Advancing the future of personalized medicine

Uncover cell and gene therapy insights from leaders across the ecosystem in the latest Deloitte NextGen Therapies State of the Industry Survey.

Unlocking the potential of cell and gene therapies

Regulatory, Legal, & Compliance

Perspectives

Life sciences compliance, pricing, and contracting insights and updates

Thought leadership collection

Life sciences compliance teams face escalating responsibilities. From strategic innovation to operational excellence, keeping up with rapidly changing regulatory environments and industry guidelines is crucial.

Blog

Impurity regs may affect life sciences pipelines, portfolios

Six steps pharma manufacturers can take to limit nitrosamines and other impurities.

Perspectives

Regulatory changes in the future of health

Engaging with regulators and staying abreast of legislative and regulatory activity will be as important as ever

Responding to new or changing regulations is a persistent challenge for health care stakeholders, and it is one that is not fading away anytime soon.

Perspectives

Discover compliance and risk management changes in our 2025 Life sciences regulatory outlook

How 2025 life sciences trends are shaping the industry

Audit, Accounting, & Finance

Analysis

2025 Life Sciences Industry Accounting Guide

Insights and guidance on life sciences accounting issues

Explore the key accounting considerations for the life sciences industry.

Article

ESG Readiness in Life Sciences and Health Care | Deloitte US

What sets life sciences and health care companies apart in their efforts to enhance ESG reporting—and what challenges are they finding along the way?

Article

Navigating a Rapid Growth Journey — Effectively and Carefully | Deloitte US

A biotech company’s forward-thinking founders started by choosing a trusted professional services provider. Read the Ripple Effect story to learn more.

Blog

Reverse merger considerations for biotech companies

Quote-with-link. Do not delete! This box/component contains JavaScript that is needed on this page. This message will not be visible when page is activated.

Connect via email

Subscribe

Contact us

Contact us via our online form

Submit RFP

Submit via our online form

Services

Audit & Assurance Services for the Life Sciences & Health Care Industry

You push to gain understanding and envision new possibilities. We’ll help you sharpen your understanding today to help you redefine tomorrow’s breakthroughs.
M&A services

From strategy through integration, Deloitte's M&A services help businesses transform during periods of financial difficulty and navigate complex decisions at every phase of an M&A transaction or divestiture.
Medical technology

Find out more about how the medical technology industry is changing through emerging technology, evolving life sciences regulations, value-based payment models, globalization, and greater consumer engagement.
Risk & Financial Advisory Services

We help organizations navigate business risks and opportunities—from strategic, reputation, and financial risks to operational, cyber, and regulatory risks.

Get in touch

Pete Lyons

Vice Chair and US Life Sciences Sector Leader, Deloitte

plyons@deloitte.com

+1 617 519 1817

John Conrad

Principal | Regulatory & Operations Risk

jconrad@deloitte.com

+1 215 246 2383

Maggie Zellers

US Life Sciences Tax Leader | Deloitte Tax LLP

mzellers@deloitte.com

+1 312 486 3621

Jeff Ellis

US & Global A&A LS Leader | LS PPD

jeellis@deloitte.com

+1 412 338 7204

@DeloitteHealth

Sharing news, research, events, and more

Join the conversation

Contact us
Search jobs
Submit RFP
Subscribe to Deloitte Insights

Global office directory US office locations

US-EN Location: United States-English

About Deloitte

About Deloitte
Client stories
My Deloitte
Deloitte Insights
Email subscriptions
Press releases
Submit RFP
US office locations
Alumni
Global office directory
Newsroom
Dbriefs webcasts
Contact us

Services

Tax
Consulting
Audit & Assurance
Deloitte Private
M&A and Restructuring
Risk & Financial Advisory
AI & Analytics
Cloud

Industries

Consumer
Energy, Resources & Industrials
Financial Services
Government & Public Services
Life Sciences & Health Care
Technology, Media & Telecommunications

Careers

Careers
Students
Experienced Professionals
Job Search
Life at Deloitte
Alumni Relations

About Deloitte
Terms of Use
Privacy
Data Privacy Framework
Cookies
Cookie Settings
Legal Information for Job Seekers
Labor Condition Applications
Do Not Sell or Share My Personal Information

© 2025. See Terms of Use for more information.

Deloitte refers to one or more of Deloitte Touche Tohmatsu Limited, a UK private company limited by guarantee ("DTTL"), its network of member firms, and their related entities. DTTL and each of its member firms are legally separate and independent entities. DTTL (also referred to as "Deloitte Global") does not provide services to clients. In the United States, Deloitte refers to one or more of the US member firms of DTTL, their related entities that operate using the "Deloitte" name in the United States and their respective affiliates. Certain services may not be available to attest clients under the rules and regulations of public accounting. Please see www.deloitte.com/about to learn more about our global network of member firms.